EventRTNovaTransforming all Tumor Sites: The Power of Systemic Enveloped VirotherapySITC 2024May 1, 2025 Posterlaunch
EventRTNovaTransforming Tumor Immune Microenvironments with a Novel Systemic Enveloped Oncolytic Virotherapy Targeting All Tumor SitesASCO Annual Meeting 2024June 24, 2024 Posterlaunch
EventSuperNovaNon-Clinical Evidence Supporting the Upcoming CLD-201 Clinical Trial: Cell-Based Oncolytic Virotherapy for Multiple Solid TumorsASCO Annual Meeting 2024June 1, 2024 Posterlaunch
EventNeuroNova & SuperNovaStem Cell Platforms for Enhanced Oncolytic VirotherapyFestival of BiologicsApril 16, 2024 Posterlaunch
EventSuperNova & NeuroNovaDeciphering Anticancer Mechanisms of Oncolytic Virus-loaded Stem CellsAmerican Association for Cancer ResearchApril 9, 2024 Posterlaunch
EventSuperNovaAnnual Meeting – SITC 2023 – Nov 1st to 5th 2023 in San Diego, CA, USA.SUPERNOVA1 (SNV1), A NOVEL ONCOLYTIC-CELL BASED PLATFORM FOR CANCER THERAPYNovember 23, 2023 Posterlaunch
EventNeuroNovaThe Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting | November 7-11, 2018 Washington, D.C.Abstract P617: A cell-based platform to protect and enhance oncolytic virus therapiesNovember 7, 2018 AbstractlaunchPosterlaunch
EventNeuroNovaThe Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting | November 7-11, 2018 Washington, D.C.Abstract P609: First in man study of TK positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cellsNovember 7, 2018 AbstractlaunchPosterlaunch
